Cerity Partners
ABBV icon

Cerity Partners’s AbbVie ABBV Stock Holding History

Cerity Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
+8,200
New +$1.82M ﹤0.01% 1554

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cerity Partners's ABBV Position: Q1 2026 in Review

Cerity Partners increased its AbbVie (ABBV) stake by 1.3% in Q1 2026, buying an estimated $3.49M and bringing the position to 1,215,422 shares worth $264M. The position accounts for 0.37% of the portfolio, ranked #48.

Cerity Partners first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $274M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cerity Partners held 1,215,422 shares of AbbVie worth $264M as of Q1 2026.
  • Cerity Partners bought 15,739 AbbVie shares in Q1 2026, an estimated $3.49M.
  • AbbVie made up 0.37% of Cerity Partners's portfolio in Q1 2026, its #48 holding.
  • Cerity Partners first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
  • Cerity Partners's AbbVie position peaked at $274M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.